New-onset Systemic Lupus Erythematosus after Methimazole Exposure Followed by Autoantibody Emergence.

Authors

Ayaka Ishida, Ryoko Asano, Satoshi Yamaguchi, Ikuma Okada, Miho Yamazaki, Naonori Sugishita, Masatoshi Kawataka, Toshiki Kido, Hiroyuki Hounoki, Masaru Kato

Published in

Internal medicine (Tokyo, Japan). Jul 11, 2026. Epub Jul 11, 2026.

Abstract

Methimazole-associated new-onset systemic lupus erythematosus (SLE) is rare and it may be difficult to distinguish from classic drug-induced lupus. We report a 19-year-old man who developed fever, polyarthralgia, rash, and ocular pain three months after initiating methimazole for Graves' disease. At symptom onset, antinuclear antibodies and ANCA were negative, and there was no hypocomplementemia. Despite methimazole withdrawal, inflammation persisted. During the subsequent clinical course, ANA and MPO-ANCA became positive, in conjunction with the emergence of anti-double-stranded DNA antibody and hypocomplementemia, thus fulfilling the classification criteria for SLE. Early seronegativity does not exclude evolving SLE and represents an important diagnostic pitfall. Clinicians should be aware that MPO-ANCA positivity may further complicate the differential diagnosis in such cases.

PMID:
42438030
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.